Obesity Services & Products

  1. TrialKit Engage For Televisits 12/29/2025

    Conduct secure video based visits, manage study schedules, and keep participants connected through a single unified platform.

  2. TrialKit Coder for Medical Coding 12/29/2025

    Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.

  3. Randomization and Trial Supply Management (RTSM) 12/29/2025

    A low‑risk, ultra‑efficient way to manage patient randomization and investigational product (IP) supply—fully unified within the TrialKit platform.

  4. Our Technology 12/5/2025

    Built From The Ground Up

    Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.

  5. Predictive Spend Modeling 12/5/2025

    Give us the opportunity to compete with your current set-up. We love a good challenge.

  6. Patient Travel And Logistics 12/5/2025

    Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.

  7. Site And Patient Payments 12/5/2025

    With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.

  8. RTSM Solutions That Adapt To Your Needs 12/5/2025

    At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.

  9. Dynamic RTSM Featuring Configurable, Pre-Validated Components 12/5/2025

    Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.

  10. Your Partner For Faster, More Advanced Phase 1 And 2 Trials 12/4/2025

    Early-phase clinical research experts, specialized in first-in-human trials, clinical pharmacology/NDA-enabling studies, and proof-of-concept studies.